Gala Pharmaceutical Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Gala Pharmaceutical Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$2.13 million for the 3-month period ending 2019-05-31, per its 10-Q filed 2019-07-23.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2019-07-23
- Gala Pharmaceutical Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-05-31 was -$2.13M.
- Gala Pharmaceutical Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-02-28 was -$599.39K.
- Gala Pharmaceutical Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2018-11-30 was -$208.05K.
- Gala Pharmaceutical Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2018-08-31 was -$716.91K.
- Gala Pharmaceutical Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2017 was -$1.98M.
- Gala Pharmaceutical Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2011 was -$19.45K.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2019-05-31 | -$2.13M 10-Q · filed 2019-07-23 | -$2.73M 10-Q · filed 2019-07-23 | -$2.94M derived: sum of 3 quarters · filed 2019-07-23 | -$3.65M derived: sum of 4 quarters · filed 2019-07-23 |
| 2019-02-28 | -$599.39K 10-Q · filed 2019-04-30 | -$807.43K derived: sum of 2 quarters · filed 2019-07-23 | -$1.52M derived: sum of 3 quarters · filed 2019-07-23 | -$1.92M derived: sum of 4 quarters · filed 2019-07-23 |
| 2018-11-30 | -$208.05K derived: 10-Q 12 month − 10-Q 9 month · filed 2019-07-23 | -$924.95K derived: sum of 2 quarters · filed 2019-07-23 | -$1.32M derived: sum of 3 quarters · filed 2019-07-23 | -$1.91M 10-Q · filed 2019-07-23 |
| 2018-08-31 | -$716.91K 10-Q · filed 2018-10-26 | -$1.12M derived: sum of 2 quarters · filed 2019-07-23 | -$1.70M 10-Q · filed 2018-10-26 | -$2.58M derived: sum of 4 quarters · filed 2019-07-23 |
| 2018-05-31 | -$398.16K 10-Q · filed 2019-07-23 | -$981.40K 10-Q · filed 2019-07-23 | -$1.86M derived: sum of 3 quarters · filed 2019-07-23 | -$2.56M derived: sum of 4 quarters · filed 2019-07-23 |
| 2018-02-28 | -$583.24K 10-Q · filed 2019-04-30 | -$1.47M derived: sum of 2 quarters · filed 2019-04-30 | -$2.16M derived: sum of 3 quarters · filed 2019-04-30 | -$2.53M derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-11-30 | -$882.19K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-15 | -$1.58M derived: sum of 2 quarters · filed 2019-04-15 | -$1.95M derived: sum of 3 quarters · filed 2019-04-15 | -$1.98M 10-K · filed 2019-04-15 |
| 2017-08-31 | -$695.19K 10-Q · filed 2018-10-26 | -$1.07M derived: sum of 2 quarters · filed 2018-10-26 | -$1.10M 10-Q · filed 2018-10-26 | |
| 2017-05-31 | -$373.10K 10-Q · filed 2018-08-01 | -$404.47K 10-Q · filed 2018-08-01 | ||
| 2011-11-30 | -$19.45K 10-K · filed 2012-03-13 | |||
| 2010-11-30 | -$621.00 10-K · filed 2012-03-13 |